Description
The role of venetoclax in the current treatment paradigm for patients with acute myeloid leukaemia
Article: The role of venetoclax in the current treatment paradigm for patients with acute myeloid leukaemia
€3.03
Related products
-
Article: Highlights in melanoma
€3.03 Add to cart -
Article: Highlights in digestive oncology
€3.03 Add to cart -
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart -
Article: Highlights in gynaecological cancers
€3.03 Add to cart
